Astera Labs's Director Alba Manuel conducted 18 sale transactions on December 1, 2025 under a pre-established 10b5-1 trading plan, selling a total of 111,620 shares of common stock. The sale prices ranged between $153.7961 and $172.575, reducing his holdings to 1,574,498 shares. Some shares are directly held through Alba 2003 Living Trust. Such large-scale reductions by directors could potentially negatively impact the company's stock price, investors should keep an eye on these signals.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments